IND234
NCT03385655
IND234
Prostate Cancer Biomarker Enrichment and Treatment Selection (PC-BETS) Study
Status:
Recruiting
II
Phase
2nd+
Line of Therapy
Any Stage
Disease Stage
Biomarker(s)
MET, WEE1
Investigational
Product
Mixed
Treatment Arms
o WEE-1 inhibitor
o cMET inhibitor
o novel non-steroidal androgen receptor (AR) antagonist
o CFI400945 PLK4 inhibitor
o Ipatasertib AKT inhibitor
o Durvalumab and Tremelimumab immunotherapy
o Carboplatin platinum based chemotherapy